Baiyunshan Pharma subsidiary gets amended drug production license

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. (SSE:600332) announced that its subsidiary, Guangzhou Baiyunshan Mingxing Pharmaceutical Co., Ltd., has received an amended "Drug Production License" from the Guangdong Provincial Drug Administration. The updated license reflects a reduction in Mingxing Pharmaceutical's production addresses, affecting related workshops, production lines, and production scope. The key changes involve removing a production address in Foshan City. The remaining approved production locations include Guangzhou's Huangpu, Haizhu, Conghua, Baiyun districts, as well as Yangchun City and Yunfu City, each designated for specific production activities ranging from injections and tablets to raw materials and traditional Chinese medicine processing. Baiyunshan Pharma stated that this change optimizes resource allocation and maintains stable production capacity to meet market demand, with no significant impact expected on the company's current period performance.